Acadia Healthcare Reports Mixed Q1: Strong Revenue Growth Offset by 51% Net Income Decline Amid Legal Costs & High Tax Rate
summarizeSummary
Acadia Healthcare reported strong Q1 revenue growth and increased operating cash flow, but GAAP net income and diluted EPS fell sharply due to higher legal settlement expenses and a significantly increased effective tax rate.
check_boxKey Events
-
Strong Revenue Growth
Revenue increased by 7.6% to $828.8 million for the three months ended March 31, 2026, compared to $770.5 million in the prior year period. Same facility revenue grew by 7.3%.
-
Significant Net Income and EPS Decline
Net income attributable to Acadia Healthcare Company, Inc. decreased by 51% to $4.1 million, and diluted earnings per share fell by 44.4% to $0.05 for Q1 2026, compared to $8.4 million and $0.09, respectively, in Q1 2025.
-
Increased Operating Cash Flow
Net cash provided by operating activities significantly increased to $61.5 million in Q1 2026, up from $11.5 million in Q1 2025, partly due to $31.5 million in insurance proceeds from the 2019 Securities Litigation.
-
Higher Legal Settlements Expense
Legal settlements expense rose to $13.8 million in Q1 2026, including an uninsured portion of $13.8 million related to the Sandoval Litigation, compared to $3.5 million in Q1 2025.
auto_awesomeAnalysis
Acadia Healthcare's Q1 2026 results present a mixed financial picture. While the company achieved robust revenue growth and a significant increase in operating cash flow, its GAAP net income and diluted EPS saw substantial declines. This divergence is primarily attributed to a notable increase in legal settlements expense, particularly an uninsured portion of the Sandoval Litigation, and a significantly higher effective tax rate due to non-deductible executive compensation and valuation allowances. Investors should weigh the positive operational performance against these bottom-line pressures and the ongoing government investigations, which introduce considerable uncertainty regarding future liabilities.
At the time of this filing, ACHC was trading at $26.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $11.43 to $28.57. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.